MEMORANDUM AND ORDER ON CLAIM CONSTRUCTION
STEARNS, District Judge.
On May 4, 2004, the Massachusetts Institute of Technology (MIT) and its licensee, Repligen Corp. (Repligen), filed suit against ImClone Systems, Inc. (ImClone), alleging that ImClone's manufacture of the cancer-fighting drug Erbitux violates U.S. Patent No. 4,663,281, "Enhanced Production of Proteinaceous Materials in Eucaryotic Cells" (the '281 patent). Before the court are the parties...
Let's get started

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.
- Updated daily.
- Uncompromising quality.
- Complete, Accurate, Current.